|
NSD1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.88854999999544E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.161300E-03 |
| Normal-vs-Stage2 |
4.380800E-04 |
| Normal-vs-Stage3 |
3.0158999997365E-07 |
| Normal-vs-Stage4 |
1.4335000000365E-06 |
| Stage1-vs-Stage2 |
1.448630E-01 |
| Stage1-vs-Stage3 |
3.839800E-03 |
| Stage1-vs-Stage4 |
9.680300E-03 |
| Stage2-vs-Stage3 |
6.017400E-01 |
| Stage2-vs-Stage4 |
5.042000E-01 |
| Stage3-vs-Stage4 |
7.982800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.32829999999851E-05 |
| Normal-vs-AfricanAmerican |
1.390500E-04 |
| Normal-vs-Asian |
4.271200E-01 |
| Caucasian-vs-AfricanAmerican |
2.967800E-01 |
| Caucasian-vs-Asian |
4.642400E-01 |
| AfricanAmerican-vs-Asian |
2.909600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.30689999999312E-05 |
| Normal-vs-Female |
1.383300E-04 |
| Male-vs-Female |
5.143600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.643180E-03 |
| Normal-vs-Age(41-60Yrs) |
9.045200E-04 |
| Normal-vs-Age(61-80Yrs) |
2.88390000002803E-06 |
| Normal-vs-Age(81-100Yrs) |
4.418000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.960200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.695400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.445600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.337790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.710600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.570200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.133600E-01 |
| Normal-vs-Grade 2 |
3.159700E-03 |
| Normal-vs-Grade 3 |
1.53800000002313E-06 |
| Normal-vs-Grade 4 |
1.80549999950763E-07 |
| Grade 1-vs-Grade 2 |
1.257220E-01 |
| Grade 1-vs-Grade 3 |
1.315820E-02 |
| Grade 1-vs-Grade 4 |
1.903210E-03 |
| Grade 2-vs-Grade 3 |
5.554100E-02 |
| Grade 2-vs-Grade 4 |
5.661000E-03 |
| Grade 3-vs-Grade 4 |
1.089450E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.065990E-02 |
| Normal-vs-ccB subtype |
3.43169999994508E-06 |
| ccA subtype-vs-ccB subtype |
3.896800E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.70000000000137E-05 |
| Normal-vs-N1 |
1.018080E-02 |
| N0-vs-N1 |
5.325400E-01 |
|
|
